These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21617596)

  • 1. Drugs for HIV infection.
    Treat Guidel Med Lett; 2011 Jun; 9(106):29-40. PubMed ID: 21617596
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV treatment series. Part 4 of 4. Decisions, decisions--starting or switching anti-HIV therapy.
    McGuire S
    Posit Aware; 2003; 14(3):31-6. PubMed ID: 12866490
    [No Abstract]   [Full Text] [Related]  

  • 3. US revises adult/adolescent antiretroviral therapy guidelines.
    IAPAC Mon; 2003 Aug; 9(8):181. PubMed ID: 14672071
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance.
    Grant PM; Zolopa AR
    Curr Opin Investig Drugs; 2010 Aug; 11(8):901-10. PubMed ID: 20721832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Highly active initial therapy without resistance development. Even after 6 years still effective HIV therapy].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():54-5. PubMed ID: 16385876
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapies. Confronting the limits of success.
    Cohen J
    Science; 2002 Jun; 296(5577):2320-4. PubMed ID: 12089422
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV therapeutics: points from the recent literature.
    Laurence J
    AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
    [No Abstract]   [Full Text] [Related]  

  • 9. [Four years without resistance--newer standard in HIV therapy].
    Dtsch Med Wochenschr; 2003 May; 128(19):1075-6. PubMed ID: 12774798
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral resistance.
    Geretti AM
    J HIV Ther; 2006 Dec; 11(4):72-3. PubMed ID: 17578209
    [No Abstract]   [Full Text] [Related]  

  • 11. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
    [No Abstract]   [Full Text] [Related]  

  • 12. Running with scissors: using antiretroviral therapy without monitoring viral load.
    Smith DM; Schooley RT
    Clin Infect Dis; 2008 May; 46(10):1598-600. PubMed ID: 18419496
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiretroviral therapy for HIV: drug resistance and sequencing.
    Burkle WS
    J Assoc Nurses AIDS Care; 2002; 13(1):76-80. PubMed ID: 11828862
    [No Abstract]   [Full Text] [Related]  

  • 14. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant HIV-1.
    Tayloe D
    Clin Infect Dis; 2004 May; 38(10):1507; author reply 1507. PubMed ID: 15156500
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunovirological outcomes and resistance patterns at 4 years of antiretroviral therapy use in HIV-infected patients in Cambodia.
    Pujades-Rodríguez M; Schramm B; Som L; Nerrienet E; Narom P; Chanchhaya N; Ferradini L; Balkan S
    Trop Med Int Health; 2011 Feb; 16(2):205-13. PubMed ID: 21087376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.
    Gilleece Y; Chadwick DR; Breuer J; Hawkins D; Smit E; McCrae LX; Pillay D; Smith N; Anderson J;
    HIV Med; 2010 Nov; 11(10):611-9. PubMed ID: 20961377
    [No Abstract]   [Full Text] [Related]  

  • 18. A guide for understanding the guidelines.
    Sharp M
    Posit Aware; 2004; 15(1):43-5. PubMed ID: 14989197
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological exposure and the development of drug resistance in HIV.
    Hoetelmans R
    Antivir Ther; 2001; 6 Suppl 2():37-47. PubMed ID: 11678477
    [No Abstract]   [Full Text] [Related]  

  • 20. Understanding the guidelines for treating HIV disease.
    Chesebro MJ; Everett WD
    Am Fam Physician; 1998 Jan; 57(2):315-22, 328. PubMed ID: 9456994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.